N-(hexadecanoyl)-beta-D-galactosylsphingosine : A D-galactosyl-N-acylsphingosine in which the ceramide N-acyl group is specified as hexadecanoyl. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
| ID Source | ID |
|---|---|
| PubMed CID | 11542139 |
| CHEBI ID | 83259 |
| MeSH ID | M0102206 |
| Synonym |
|---|
| n-palmitoylgalactosylsphingosine |
| 34324-89-5 |
| n-palmitoylpsychosine |
| CHEBI:83259 |
| n-(hexadecanoyl)-1-beta-galactosyl-sphing-4-enine |
| beta-d-galactosyl-n-hexadecanoylsphingosine |
| n-(palmitoyl)-beta-d-galactosylsphingosine |
| n-hexadecanoyl-beta-d-galactosyl-sphing-4-enine |
| n-(hexadecanoyl)-beta-d-galactosylsphingosine |
| n-[(2s,3r,4e)-1-(beta-d-galactopyranosyloxy)-3-hydroxyoctadec-4-en-2-yl]hexadecanamide |
| beta-d-galactosyl-n-palmitoylsphingosine |
| n-[(e,2s,3r)-3-hydroxy-1-[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoctadec-4-en-2-yl]hexadecanamide |
| hexadecanamide, n-[(1s,2r,3e)-1-[(beta-d-galactopyranosyloxy)methyl]-2-hydroxy-3-heptadecen-1-yl]- |
| n-palmitoyl cerebroside |
| Q27105092 |
| hexadecanamide,n-[(1s,2r,3e)-1-[(beta-d-galactopyranosyloxy)methyl]-2-hydroxy-3-heptadecen-1-yl]- |
| DTXSID901120367 |
| n-[(1s,2r,3e)-1-[(beta-d-galactopyranosyloxy)methyl]-2-hydroxy-3-heptadecen-1-yl]hexadecanamide |
| c16 galactosylceramide (d18:1/16:0) |
| Role | Description |
|---|---|
| mouse metabolite | Any mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus). |
| [role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
| Class | Description |
|---|---|
| N-acyl-beta-D-galactosylsphingosine | An N-acyl-D-galactosylsphingosine in which the anomeric configuration of the galactosyl residue is beta; sphingosine substituted at the O-1 position by a beta-D-galactosyl group and at the N-2 position by an acyl group. |
| HexCer(d18:1/16:0) | A cerebroside in which the ceramide N-acyl group is specified as hexadecanoyl. |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 6 (46.15) | 18.7374 |
| 1990's | 3 (23.08) | 18.2507 |
| 2000's | 1 (7.69) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (23.08) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 1 (7.69%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 12 (92.31%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||